With innovation and the medical demand for technological improvements moving at an everincreasing rate and with regulatory burden moving in parallel, MedTech organisations are under more pressure to re-examine their current and GTM strategies or devise sophisticated ways at growing and competing in what is continuing to be a turbulent period. The notion of outsourced solutions that can yield timely commercial access with competitive or first mover advantage whilst mitigating risk is without a doubt an attractive one.